ACASTI PHARMA INC's ticker is ACST and the CUSIP is 00430K402. A total of 3 filers reported holding ACASTI PHARMA INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $101,000 | -55.5% | 179,088 | -52.7% | 0.00% | – |
| Q1 2021 | $227,000 | +1646.2% | 378,808 | +885.6% | 0.00% | – |
| Q4 2020 | $13,000 | +62.5% | 38,436 | +1.0% | 0.00% | – |
| Q3 2020 | $8,000 | -75.0% | 38,072 | -44.0% | 0.00% | – |
| Q2 2020 | $32,000 | -47.5% | 67,969 | -57.7% | 0.00% | – |
| Q1 2020 | $61,000 | -86.0% | 160,785 | -9.9% | 0.00% | – |
| Q4 2019 | $437,000 | +2200.0% | 178,439 | +1637.5% | 0.00% | – |
| Q3 2019 | $19,000 | -63.5% | 10,270 | -77.5% | 0.00% | – |
| Q2 2019 | $52,000 | +33.3% | 45,687 | +20.6% | 0.00% | – |
| Q1 2019 | $39,000 | +21.9% | 37,898 | 0.0% | 0.00% | – |
| Q4 2018 | $32,000 | -38.5% | 37,898 | -5.3% | 0.00% | – |
| Q3 2018 | $52,000 | +126.1% | 40,000 | 0.0% | 0.00% | – |
| Q2 2018 | $23,000 | -43.9% | 40,000 | 0.0% | 0.00% | – |
| Q1 2018 | $41,000 | +7.9% | 40,000 | 0.0% | 0.00% | – |
| Q4 2017 | $38,000 | +3700.0% | 40,000 | +5614.3% | 0.00% | – |
| Q3 2017 | $1,000 | – | 700 | +4566.7% | 0.00% | – |
| Q1 2016 | $0 | – | 15 | -16.7% | 0.00% | – |
| Q4 2015 | $0 | – | 18 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Virtu Financial LLC | 145,202 | $137,000 | 0.01% |
| Perceptive Advisors | 186,559 | $176,000 | 0.01% |
| INTACT INVESTMENT MANAGEMENT INC. | 88,990 | $106,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 8,630 | $8,000 | 0.00% |
| TORONTO DOMINION BANK | 7 | $0 | 0.00% |
| DEUTSCHE BANK AG\ | 252,603 | $238,000 | 0.00% |
| MORGAN STANLEY | 40,000 | $38,000 | 0.00% |
| BANK OF MONTREAL /CAN/ | 212 | $0 | 0.00% |
| Citadel Advisors | 25,980 | $24,000 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 559,835 | $528,000 | 0.00% |